Abstract:Prion diseases are fatal neurodegenerative disorders where the formation of amyloids is thought to be infectious by templating their conformation on to natively-folded counterparts. Postulated nearly four decades ago, the search for the mechanism behind the conformational templating has proceeded to no avail. Here, we extend the thermodynamic hypothesis of protein folding (Anfinsen's dogma) to the amyloid phenomenon and illustrate that the amyloid conformation (cross-β) is one of two conformational states that are thermodynamically accessible to any protein sequence depending on concentration. A protein spontaneously assumes its native conformation below supersaturation and the amyloid cross-β conformation above supersaturation. The information to adopt the native conformation and the amyloid conformation is present in the primary sequence and the backbone of the protein, respectively, and does not require templating. The rate-limiting step for proteins to adopt the cross-β conformation of amyloid is termed nucleation, which can be catalyzed by surfaces (heterogeneous nucleation) or preformed amyloid fragments (seeding). Irrespective of the nucleation pathway, once triggered, amyloid formation proceeds spontaneously in fractal-like fashion, where the surfaces of the growing fibrils act as heterogeneous nucleation catalysts for new fibrils, a phenomenon known as secondary nucleation. This pattern is in contrast to the linear growth assumptions that the prion hypothesis necessitates for faithful prion strain replication. Additionally, the cross-β conformation buries the majority of the protein side chain inside the fibrils, making the fibrils inert, generic, and extremely stable. As such, the source of toxicity in prion disorders may come to a greater extent from the loss of proteins in their normal, soluble, and therefore functional state rather than from their transformation into stable, insoluble, nonfunctioning amyloids.

The multiphysics of prion-like diseases: progression and atrophy

Spatially-extended nucleation-aggregation-fragmentation models for the dynamics of prion-like neurodegenerative protein-spreading in the brain and its connectome

Dysfunction of microtubule-associated proteins of MAP2/tau family in Prion disease.

Dysfunction of Microtubule-Associated Proteins of MAP2/tau Family in Prion Disease

Prion-like spreading of Alzheimer’s disease within the brain’s connectome

The dynamics of prion spreading is governed by the interplay between the non-linearities of tissue response and replication kinetics

A network aggregation model for the dynamics and treatment of neurodegenerative diseases at the brain scale

Oscillations in neuronal activity: a neuron-centered spatiotemporal model of the Unfolded Protein Response in prion diseases

A unified model for the origins of spongiform degeneration and other neuropathological features in prion diseases

The allure and pitfalls of the prion-like aggregation in neurodegeneration

Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases

Deciphering the prion-like behavior of pathogenic protein aggregates in neurodegenerative diseases

A Multiscale Closed-Loop Neurotoxicity Model of Alzheimer's Disease Progression Explains Functional Connectivity Alterations

Bimodality, prion aggregates infectivity and prediction of strain phenomenon

Prion-Like Propagation of Protein Misfolding and Aggregation in Amyotrophic Lateral Sclerosis

Prionoid Proteins in the Pathogenesis of Neurodegenerative Diseases

Local vulnerability and global connectivity jointly shape neurodegenerative disease propagation

Neuron-to-Neuron Transmission of Neurodegenerative Pathology

Attempt to Untangle the Prion-Like Misfolding Mechanism for Neurodegenerative Diseases

Mechanisms of prion-induced toxicity